GRN and neoplasm: The downregulated expression, upon Ape treatment, of factors typically overexpressed in hypoxic conditions, such as miR-210, progranulin and VEGFR, suggest that the M2 receptor activation may be a strategic therapeutic tool to counteract GSCs cell proliferation, survival and stemness properties that normally promote tumor aggressiveness typically associated with O2 deprivation.